中华内分泌代谢杂志
中華內分泌代謝雜誌
중화내분비대사잡지
CHINESE JOURNAL OF ENDOCRINOLOGY AND METABOLISM
2010年
9期
749-753
,共5页
刘蕴玲%阴东亮%刘好田%周叶英%李淑英%程慧玲%周聊生
劉蘊玲%陰東亮%劉好田%週葉英%李淑英%程慧玲%週聊生
류온령%음동량%류호전%주협영%리숙영%정혜령%주료생
肥胖%儿童%代谢综合征%脂联素%动脉粥样硬化
肥胖%兒童%代謝綜閤徵%脂聯素%動脈粥樣硬化
비반%인동%대사종합정%지련소%동맥죽양경화
Obesity%Children%Metabolic syndrome%Adiponectin%Atherosclerosis
目的 研究脂联素在肥胖儿童极早期动脉粥样硬化形成过程中所起的保护性作用,评价血清脂联素水平对儿童代谢综合征的诊断价值.方法 选择176例肥胖和88名非肥胖年龄9~12岁的儿童,酶联免疫法(ELISA)检测血清脂联素水平,收集身高、体重、腰围、血压、胰岛素、超敏C反应蛋白(hsCRP)、血脂、血糖等临床资料,计算稳态模型评估的胰岛素抵抗指数(HOMA-IR).超声测量颈动脉内中膜层厚度(IMT)、颈动脉血管顺应性(CAC)、内皮依赖的血管舒张功能(FMD)和最大的腹膜前脂肪厚度(Pmax).结果 (1)脂联素与肥胖指标、血压、低密度脂蛋白胆固醇、空腹胰岛素、HOMA-IR、hsCRP、IMT呈显著负相关(P<0.05或P<0.01),与甘油三酯、空腹血糖、CAC、高密度脂蛋白胆固醇(HDL-C)、FMD无显著相关性(P>0.05).(2)以脂联素水平7.060 mg/L为切点,<7.060 mg/L的儿童发生代谢综合征的危险是>7.060 mg/L的4.43倍.(3)用血清脂联素水平判断代谢综合征诊断的敏感性,曲线下面积为0.769(95%CI0.714~0.816,P<0.01).(4)根据血清脂联素水平将肥胖儿童分为高、中、低3组,重度肥胖、内脏脂肪积聚、高血压、高胰岛素血症、低HDL-C、代谢综合征患病率3组间比较有显著性差异(P<0.05).结论 提高肥胖儿童血清脂联素水平有助于预防极早期动脉粥样硬化的发生.脂联素越低的儿童,患代谢综合征的可能性似越大.
目的 研究脂聯素在肥胖兒童極早期動脈粥樣硬化形成過程中所起的保護性作用,評價血清脂聯素水平對兒童代謝綜閤徵的診斷價值.方法 選擇176例肥胖和88名非肥胖年齡9~12歲的兒童,酶聯免疫法(ELISA)檢測血清脂聯素水平,收集身高、體重、腰圍、血壓、胰島素、超敏C反應蛋白(hsCRP)、血脂、血糖等臨床資料,計算穩態模型評估的胰島素牴抗指數(HOMA-IR).超聲測量頸動脈內中膜層厚度(IMT)、頸動脈血管順應性(CAC)、內皮依賴的血管舒張功能(FMD)和最大的腹膜前脂肪厚度(Pmax).結果 (1)脂聯素與肥胖指標、血壓、低密度脂蛋白膽固醇、空腹胰島素、HOMA-IR、hsCRP、IMT呈顯著負相關(P<0.05或P<0.01),與甘油三酯、空腹血糖、CAC、高密度脂蛋白膽固醇(HDL-C)、FMD無顯著相關性(P>0.05).(2)以脂聯素水平7.060 mg/L為切點,<7.060 mg/L的兒童髮生代謝綜閤徵的危險是>7.060 mg/L的4.43倍.(3)用血清脂聯素水平判斷代謝綜閤徵診斷的敏感性,麯線下麵積為0.769(95%CI0.714~0.816,P<0.01).(4)根據血清脂聯素水平將肥胖兒童分為高、中、低3組,重度肥胖、內髒脂肪積聚、高血壓、高胰島素血癥、低HDL-C、代謝綜閤徵患病率3組間比較有顯著性差異(P<0.05).結論 提高肥胖兒童血清脂聯素水平有助于預防極早期動脈粥樣硬化的髮生.脂聯素越低的兒童,患代謝綜閤徵的可能性似越大.
목적 연구지련소재비반인동겁조기동맥죽양경화형성과정중소기적보호성작용,평개혈청지련소수평대인동대사종합정적진단개치.방법 선택176례비반화88명비비반년령9~12세적인동,매련면역법(ELISA)검측혈청지련소수평,수집신고、체중、요위、혈압、이도소、초민C반응단백(hsCRP)、혈지、혈당등림상자료,계산은태모형평고적이도소저항지수(HOMA-IR).초성측량경동맥내중막층후도(IMT)、경동맥혈관순응성(CAC)、내피의뢰적혈관서장공능(FMD)화최대적복막전지방후도(Pmax).결과 (1)지련소여비반지표、혈압、저밀도지단백담고순、공복이도소、HOMA-IR、hsCRP、IMT정현저부상관(P<0.05혹P<0.01),여감유삼지、공복혈당、CAC、고밀도지단백담고순(HDL-C)、FMD무현저상관성(P>0.05).(2)이지련소수평7.060 mg/L위절점,<7.060 mg/L적인동발생대사종합정적위험시>7.060 mg/L적4.43배.(3)용혈청지련소수평판단대사종합정진단적민감성,곡선하면적위0.769(95%CI0.714~0.816,P<0.01).(4)근거혈청지련소수평장비반인동분위고、중、저3조,중도비반、내장지방적취、고혈압、고이도소혈증、저HDL-C、대사종합정환병솔3조간비교유현저성차이(P<0.05).결론 제고비반인동혈청지련소수평유조우예방겁조기동맥죽양경화적발생.지련소월저적인동,환대사종합정적가능성사월대.
Objective To evaluate the protective effect of adiponectin in early atherosclerosis and the diagnostic value of adiponectin in metabolic syndrome in obese children. Methods Total 176 obese children and 88 normal weight children aged 9-12 years were included in the present study. All participants underwent hematologic and biochemical tests including serum adiponectin, high sensitivity C-reactive protein (hsCRP),fasting blood glucose, insulin, and plasma lipids. Homeostasis model assessment of insulin resistance (HOMA-IR)was calculated. Noninvasive ultrasound measurement including intima-media thickness of the common carotid artery(IMT), brachial flow-mediated dilatation (FMD), carotid artery compliance (CAC), and the maximum fatthickness ahead of peritoneum (Pmax) were obtained to investigate arterial mechanical properties and endothelial function. Results (1) The level of adiponectin was negatively correlated with obese index, blood pressure,fasting insulin, hsCRP, HOMA-IR, and IMT(P<0.05 or P<0. 01 ); but not with triglyceride, fasting blood glucose, CAC, high-density lipoprotein-cholesterol (HDL-C), and FMD. (2) The risk of metabolic syndrome increased 3.43 times in children with adiponectin level <7. 060 mg/L compared with >7. 060 mg/L. (3)Receiver operating characteristic( ROC ) curve was used to choose the optimal cutpoint of adiponectin to identify obese children with the metabolic syndrome. The area under the curve (AUC) for adiponectin to discriminate the sensitivity of metabolic syndrome was 0. 769 (95% CI0. 714-0.816, P< 0. 0 1 ). (4) The obese children were divided into three groups according to the cut-off value for adiponectin (high, middle, low groups). There were significant differences in the prevalences of severe obesity, visceral fat accumulation, hypertension, insulinemia,low HDL-C, metabolic syndrome among three groups (P<0.05). Conclusions High levels of serum adiponectin could prevent early stage of atherosclerosis. The lower the adiponectin level, the higher the incidence of metabolic syndrome.